share_log

睿智医药(300149.SZ):具备包括多肽及小分子在内的化学设计与合成的能力

Chempartner Pharmatech (300149.SZ): Possesses the capability of chemical design and synthesis, including peptides and small molecules.

Gelonghui Finance ·  Aug 9 06:04

Chempartner Pharmatech (300149.SZ) stated on the investor interaction platform on August 9th that the company has the ability to design and synthesize chemicals, including peptides and small molecules, as well as corresponding research and development capabilities such as drug screening models, which can help innovative drug customers, including weight loss drugs, to promote the development of related drugs.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment